ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
July 31, 2024 16:01 ET
|
ALX Oncology
Evorpacept is the first CD47 blocker to show durable clinical benefit and a well-tolerated safety profile in a prospective randomized trial Evorpacept combination achieved a confirmed overall...
Enovix Announces Second Quarter 2024 Financial Results
July 31, 2024 16:01 ET
|
Enovix Corporation
FREMONT, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for second quarter 2024,...
PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
July 31, 2024 16:01 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
Standard BioTools Reports Second Quarter 2024 Financial Results
July 31, 2024 16:01 ET
|
Standard BioTools Inc.
Standard BioTools Reports Second Quarter 2024 Financial Results
Kaixin Holdings Announces Receipt of Nasdaq Letter Regarding Second Minimum Bid Price Compliance Period
July 31, 2024 16:00 ET
|
Kaixin Holdings
BEIJING, July 31, 2024 (GLOBE NEWSWIRE) -- Kaixin Holdings ("Kaixin" or the "Company") (NASDAQ: KXIN) today announced the receipt of a notification letter (the “Nasdaq Letter”) dated July 31, 2024...
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR
July 31, 2024 16:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, July 31, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...
HilleVax Announces Reduction in Force
July 31, 2024 16:00 ET
|
HilleVax, Inc.
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...
Runway Growth Finance Corp. Announces Third Quarter Regular Dividend of $0.40 and $0.05 Supplemental Distribution
July 31, 2024 15:03 ET
|
Runway Growth Finance Corp.
MENLO PARK, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and...
StoneX Group Inc. to Announce 2024 Fiscal Third Quarter Earnings on August 6, 2024
July 31, 2024 15:00 ET
|
StoneX Group Inc.
NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2024 third quarter results after the market close on Tuesday, August 6,...
AvePoint Announces General Availability of Cloud Backup Express
July 31, 2024 15:00 ET
|
AvePoint, Inc.
JERSEY CITY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), a global leader in data management and data governance, today announced the general availability of AvePoint Cloud...